𝔖 Bobbio Scriptorium
✦   LIBER   ✦

587 - The treatment of schizophrenia with partial dopamine agonist: A promising strategy

✍ Scribed by Adrienne C. Lahti; Robert A. Lahti; Arvid Carlsson; Carol A. Tamminga

Book ID
119559511
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
110 KB
Volume
24
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of parkinson's disease with th
Treatment of parkinson's disease with the partial dopamine agonist EMD 49980
✍ Daniele Bravi; Thomas L. Davis; M. Maral Mouradian; Dr. Thomas N. Chase πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

## Abstract The motor effects of the partial dopamine agonist EMD 49980 were evaluated in parkinsonian patients under controlled conditions. EMD 49980 monotherapy resulted in a mild improvement in parkinsonian symptoms, but when co‐administered with levodopa, had no significant effect on dyskinesia

The effect of dopamine partial agonists
The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia
✍ Se Hee Kim; Doug Hyun Han; So Youn Joo; Kyung Joon Min πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract ## Objective We compared the effects of haloperidol and three atypical antipsychotics (risperidone, olanzapine, and aripiprazole) on nicotine dependence in schizophrenic patients. ## Methods One hundred and thirty nine schizophrenic patients, who began using antipsychotic medication,